Inclusion criteria
  1. Aged between 4 and 11 months of age
  2. IgE-mediated peanut allergy diagnosed by an allergist with positive SPT (≥3mm) or serum sIgE (>0.35ku/L) to peanut
  3. A legally acceptable representative capable of understanding the informed consent document.